Financial Update of Boston Scientific Corporation (NYSE:BSX)


Quarterly Sales and EPS Roundup:

Boston Scientific Corporation (BSX) reported sales (ttm) of 8.71 Billion, whereas, 20 number of analysts estimated the mean sale of 2328.83 million. The analysts estimated sales for the higher end at 2384 million and lower end at 2299 million while the year ago reported sale was 2262.56 million.

8 number of analysts have estimated the sales of the company for the quarter ending Oct 26, 2017, analysts estimated mean sale target of 2307.95 million while high and low sale targets are estimated at 2360.11 million and 2267 million respectively.

Boston Scientific Corporation (BSX) reported earning per shares for the quarter ending Oct 26 BMO at 0.32, whereas, 22 number of analysts estimated the mean EPS at 0.34. The analysts estimated EPS for the higher end at 0.35 and lower end at 0.33 while the year ago reported earnings per share was 0.33.

The company has mean EPS estimate of 0.32 reported by 12 number of analyst for the quarter ending Current Qtr.(Sep2017). The analysts estimated mean EPS at 0.32 while the high and low EPS estimate stand at 0.35 and 0.29 respectively. In contrast to the year ago quarter EPS was at 0.32. EPS long term mean growth rate estimated by 7 analysts is at 11.54%, whereas, the high and low Long term growth rate estimated at 14.6 and 8.6.

Valuation Ratios of Boston Scientific Corporation (BSX) versus the Industry and Sector:

Let’s have a look at some of the important valuation ratios of the Boston Scientific Corporation (BSX). These ratios are important while doing valuation of the company or the shares of the company.

Boston Scientific Corporation (BSX) currently the company’s industry has 13.86 P/E and the sector P/E is 16.24. The industry’s and sector’s  high P/E for the past year is 113.68 and 31.67 respectively and low P/E ratio for the last 5 years is 6.78 for the industry and 10.26 for the Sector.

Beta is also an important valuation ratio for analyzing the stock of the company, BSX has its industry and Sector’s beta remains at 0.9 and 0.77 respectively.

The industry and sector ratio of Price to Cash Flow ticked at 7.64 and 9.99 respectively.

5 Year Growth Rate Analysis:

Growth rates are very important while analyzing the long term growth and valuation of a certain company.

5 year sales growth rate is an important factor for valuation analysis, the industry’s and the sector’s growth for next 5 years ticked at -2.36 and -8.01 respectively.

Boston Scientific Corporation (BSX) Trading Statistics:

The company surged 0.55% and closed its last trading session at $29.27. The market capitalization of the company is at $40.31 Billion. The stock touched 52-week High of $29.54 on 10/09/17 and 52-week Low of $19.67 on 12/01/16. The stock currently has Weekly Volatility of 0.82% and Monthly Volatility of 1.10%. The Beta for the company stands at 1.03 and its Average True Range (ATR) shows a value of 0.34.